ROBERT C. LAMB, JR. NAMED SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER AT RECOLL MANAGEMENT CORP.
ROBERT C. LAMB, JR. NAMED SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER AT RECOLL MANAGEMENT CORP. BOSTON, Dec. 30 /PRNewswire/ -- Robert C. Lamb, Jr. has been named senior vice president and chief financial officer of RECOLL Management Corp., it was announced today by Irving J. Goss, controller of Fleet/Norstar Financial Group (NYSE: FNG), Providence, R.I., parent company of RECOLL. Based in Boston, RECOLL is one of the three largest nonbank asset management companies in the nation. It was established earlier this year specifically to manage, collect and liquidate a pool of assets acquired by the Federal Deposit Insurance Corp. from failed banks. Lamb, 36, joined Fleet/Norstar's data processing subsidiary as controller in 1986, and was named controller of Fleet/Norstar Services Corp. in 1988. He was named controller of another affiliate, Fleet Credit Corp., in 1990 and was named a vice president of that subsidiary in 1991. Previously, Lamb was a manager in the Washington D.C. office of Peat Marwick, Mitchell & Co., and served as an officer in the U.S. Army. A graduate of the United States Military Academy at West Point, Lamb also holds a master's degree in business administration from Long Island University. He and his family live in Barrington, R.I. Fleet/Norstar Financial Group is a diversified financial services company listed on the New York Stock Exchange. Fleet/Norstar has approximately 1,300 offices nationwide. Its lines of business include commercial and consumer banking, mortgage banking, consumer finance, asset-based lending, trust banking, student loan processing, and investment banking. -0- 12/30/91 /CONTACT: Robert W. Lougee, Jr., 401-278-5879; or Bruce P. Crooks, 401-278-6241; or Charles T. Conway, Jr., 401-278-6240; or Thomas L. Lavelle, 617-573-7733; all of Fleet/Norstar/ (FNG) CO: Fleet/Norstar Financial Group ST: Rhode Island IN: FIN SU: PER
DD-PB -- NE003 -- 5629 12/30/91 11:43 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 30, 1991|
|Previous Article:||NOVA PHARMACEUTICAL SEEKS FDA APPROVAL TO BEGIN HUMAN TESTING OF A NEW TREATMENT FOR SEPSIS AND SEPTIC SHOCK|
|Next Article:||CRUM AND FORSTER AND BURNS & WILCOX SIGN DEFINITIVE AGREEMENT FOR THE SALE OF FLOYD WEST & COMPANY|